Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/ATYR-PHARMA-INC-60951391/news/ATyr-Pharma-Announces-Dosing-of-First-Patient-in-Phase-2-EFZO-CONNECT-Study-of-Efzofitimod-in-Pat-45197548/?utm_source=whatsapp&utm_medium=social&utm_campaign=share